NCT05079724 is a clinical trial of Cardiac Surgery in Heart Diseases, sponsored by Assiut University.

Who is sponsoring NCT05079724?

NCT05079724 is sponsored by Assiut University.

What drugs are being tested in NCT05079724?

Interventions in NCT05079724: Cardiac Surgery.

What condition does NCT05079724 study?

NCT05079724 studies Heart Diseases, Heart Valve Diseases, Heart Shock, Cardiac Disease, Cardio-Renal Syndrome, Cardio Respiratory Arrest, Cardiopulmonary Disease, Cardiopulmonary Arrest With Successful Resuscitation, Cardio-pulmonary Bypass, Cardiothoracic Surgery, Acute Kidney Injury, Acute Kidney Injury Due to Circulatory Failure, Coronary Artery Bypass Surgery.

Is NCT05079724 still recruiting?

NCT05079724 is currently status unknown. Last updated 19 October 2021.

Last reviewed 2021-10-19 · How we verify

NCT05079724

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute Kidney Injury After Cardiac Surgery

Status unknown Last updated 19 October 2021

What this trial tests

trial testing Cardiac Surgery in Heart Diseases in 200 participants. Status unknown.

Timeline

1 November 2021

Primary endpoint
1 October 2024

1 November 2024

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 November 2021
Primary completion	1 October 2024
Estimated completion	1 November 2024

Drugs / interventions tested

Cardiac Surgery

Conditions studied

Heart Diseases — all drugs for Heart Diseases →
Heart Valve Diseases — all drugs for Heart Valve Diseases →
Heart Shock — all drugs for Heart Shock →
Cardiac Disease — all drugs for Cardiac Disease →

Sponsor

Assiut University

Who can join

Adults 18 to 80, any sex, with Heart Diseases or Heart Valve Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to identify the Following: - 1. incidence and mortality of cardiac Surgery associated -AKI based on the new consensus diagnostic systems of KDIGO (Kidney Disease Improving Global Outcomes). 2. use of biomarkers for the early detection of clinical and subclinical cardiac Surgery associated-AKI. 3. risk factors and prediction models of cardiac Surgery associated-AKI. 4. optimal cardiac surgical procedures including conventional versus minimally invasive approaches, on-pump versus off-pump, and optimal management of cardiac surgical support including duration of CPB, perfusion pressure, hemodilution, and hypothermia during CPB. 5. controversial pharmacologic therapies for the prevention and treatment of cardiac Surgery associated-AKI including statins, sodium bicarbonate, and N-acetylcysteine (NAC).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cardiac Surgery

Trials testing the same drug.

NCT05333146 — Outcomes After Perioperative Stroke Following Cardiac Surgery · unknown
NCT04231461 — Quality of Life After Cardiac Surgery · completed
NCT02963480 — Investigation of Inflammatory Parameters in a Perioperative Closed-meshed Standard Progress in CPB Patients · completed
NCT03552887 — Adverse Events During Physiotherapy at Intensive Care Unit In Patients Undergoing Cardiac Surgery · completed

Other recruiting trials for Heart Diseases

Currently open trials in the same condition.

NCT07288216 — Transition to KPL-387 Monotherapy Dosing & Administration Study · Phase 2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
NCT06769880 — Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Fa · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05079724 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 19 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05079724.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing